(Q82975759)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16565894%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

29 December 2023

https://doi.org/10.1007/s10067-021-05788-3

http://retractionwatch.com/?s=yoshihiro+sato

title

Comparison of the effect of alendronate on lumbar bone mineral density and bone turnover in men and postmenopausal women with osteoporosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16565894%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Jun Iwamoto

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16565894%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Tsuyoshi Takeda

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16565894%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Yoshihiro Sato

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16565894%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Mitsuyoshi Uzawa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16565894%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

25 March 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16565894%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

published in

Clinical Rheumatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16565894%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16565894%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16565894%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

161-167

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16565894%20AND%20SRC:MED&resulttype=core&format=json

Unresolved issues in osteoporosis in men.

18 January 2020

cites work

1 reference

12 December 2020

Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment

1 reference

12 December 2020

Alendronate Treatment in Men With Primary Osteoporosis: A Three-Year Longitudinal Study

1 reference

12 December 2020

Diagnostic criteria for primary osteoporosis: year 2000 revision

1 reference

12 December 2020

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group

1 reference

12 December 2020

Alendronate for the Treatment of Osteoporosis in Men

1 reference

12 December 2020

Treatment of male osteoporosis: recent advances with alendronate

1 reference

12 December 2020

Early changes in urinary cross-linked N-terminal telopeptides of type I collagen level correlate with 1-year response of lumbar bone mineral density to alendronate in postmenopausal Japanese women with osteoporosis

1 reference

12 December 2020

Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study

1 reference

12 December 2020

Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial

1 reference

12 December 2020

Guidelines for the use of biochemical markers of bone turnover in osteoporosis (2004)

1 reference

12 December 2020

Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. Phase III Osteoporosis Treatment Study Group

1 reference

12 December 2020

The roles of bone mineral density, bone turnover, and other properties in reducing fracture risk during antiresorptive therapy

1 reference

12 December 2020

Pharmacotherapy of osteoporosis in men.

1 reference

12 December 2020

A double-masked multicenter comparative study between alendronate and alfacalcidol in Japanese patients with osteoporosis. The Alendronate Phase III Osteoporosis Treatment Research Group

1 reference

12 December 2020

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

12 December 2020

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

1 reference

12 December 2020

Ten years' experience with alendronate for osteoporosis in postmenopausal women

1 reference

12 December 2020

Effects of alendronate on bone density in men with primary and secondary osteoporosis

1 reference

12 December 2020

Bone mass and biochemical parameters of bone metabolism in men with spinal osteoporosis

1 reference

12 December 2020

Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis

1 reference

12 December 2020

10.1007/S10067-006-0252-Z

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16565894%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference